NEW YORK (GenomeWeb News) – Beckman Coulter has priced two senior notes offerings and has filed a prospectus to sell up to $250 million worth of common stock, which will help pay for its $780 million acquisition of Olympus' diagnostics business.

The offerings were expected, as Beckman said in late February that it would pay for the acquisition through a combination of around $500 million worth of new debt and roughly $300 million of its common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.